CoreAge Rx vs Lyfe Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Lyfe Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Lyfe Rx
FDA warning letter, September 2025 — issued to Lyfe Rx. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Lyfe Rx a bad call — it's best for people comparing one-time and multi-month compounded treatment who confirm the actual supply, format and refill obligations before paying. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Lyfe Rx |
|---|---|---|
| Brief Score | 94/100 (A) | 64/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $275 one-time fill; supply unconfirmed Catalog monthly autoship $225.50; three-month autoship $618.75 ($206.25/month displayed). Full payment due at purchase; confirm dose, exact supply and next-fill terms. No membership; shipping excludes Alabama. Refund page permits a pre-fill refund less intake/doctor fees; $50 wording is ambiguous. Terms state no refunds with case-by-case discretion. Obtain applicable terms; packaged prescriptions final sale. Full price detailsCompounded semaglutide weekly injection offered; complete selected-prescription quote unknown; catalog one-time $275 per fill, monthly autoship $225.50, three-month autoship $618.75 ($206.25/month) displayed; confirm dose and exact supply |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $399 one-time fill; supply unconfirmed Catalog monthly autoship $327.18; three-month autoship $897.75 ($299.25/month displayed). Full payment due at purchase; confirm dose, exact supply and next-fill terms. No membership; shipping excludes Alabama. Refund page permits a pre-fill refund less intake/doctor fees; $50 wording is ambiguous. Terms state no refunds with case-by-case discretion. Obtain applicable terms; packaged prescriptions final sale. Full price detailsCompounded tirzepatide weekly injection offered; complete selected-prescription quote unknown; catalog one-time $399 per fill, monthly autoship $327.18, three-month autoship $897.75 ($299.25/month) displayed; confirm dose and exact supply |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ says U.S. shipping except Alabama; patient-state clinical eligibility and pharmacy restrictions still apply |
| Brand-name access | Not confirmed | The reviewed GLP-1 products are compounded; a current named branded GLP-1 offer was not established. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Lyfe Rx: One-time and autoship catalog prices differ; full payment due at purchase, selected supply unconfirmed. Alabama excluded. Pre-fill refund wording conflicts with stricter Terms; intake/doctor deduction needs itemization.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.